FibroGen Inc. | Mutual Funds
Mutual Funds that own FibroGen Inc.
Fidelity Contrafund
2,249,058
2.67%
-6,943
0.1%
07/31/2018
Fidelity Select Biotechnology Portfolio
1,976,519
2.34%
-29,100
1.32%
07/31/2018
Vanguard Small Cap Index Fund
1,891,834
2.24%
26,076
0.12%
07/31/2018
Vanguard Total Stock Market Index Fund
1,885,477
2.24%
1,840
0.02%
07/31/2018
iShares Russell 2000 ETF
1,570,156
1.86%
-840
0.2%
09/06/2018
First Trust NYSE Arca Biotechnology Index Fund
1,138,047
1.35%
0
3%
09/05/2018
SPDR S&P Biotech ETF
1,127,738
1.34%
2,901
1.18%
09/06/2018
Vanguard Small Cap Growth Index Fund
1,079,901
1.28%
15,948
0.26%
07/31/2018
Vanguard Extended Market Index Fund
1,026,541
1.22%
6,888
0.09%
07/31/2018
iShares Nasdaq Biotechnology ETF
966,481
1.14%
-12,642
0.6%
09/06/2018
| Address |
409 Illinois Street
San Francisco California 94158
United States
|
|
Employees
|
- |
| Website |
http://www.fibrogen.com |
| Updated |
07/08/2019 |
| FibroGen, Inc. engages in the discovery, development, and commercialization of therapeutics to treat unmet medical needs. It focuses on fibrosis and hypoxia-induced factor biology to generate programs targeting therapeutic areas. The company was founded by Thomas B. |
